[Raltegravir for the treatment of human immunodeficiency virus infection]
Secco A, Garcia Martí Sebastián, Pichon-Riviere A, Augustovski F, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L
Record ID 32015001161
Spanish
Authors' recommendations:
High-methodological quality evidence showed that raltegravir is efficacious for the treatment of adult patients infected with the immunodeficiency virus both in naive and previous treatment failures. Most clinical practice guidelines consider it a good option for children and for patients co-infected with hepatitis C and after exposure to potentially contagious sources. Some of them mention their costs as a limitation to its potential use. The recommendations and coverage policies surveyed consider its use, although the World Health Organization limits its use to the cases with prior treatment failure.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.iecs.org.ar/publicacion/?id=5225
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Humans
- HIV Infections
- Pyrrolidinones
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.